19
Aug
The escalating trade tensions between Washington and Brussels took a significant turn as former U.S. President Donald Trump agreed to withdraw plans for imposing an extraordinarily high tariff—reportedly 250 percent—on pharmaceutical imports from the European Union. This decision, which came as part of a broader trade arrangement, marks a critical moment in the long-standing negotiations between the two economic powerhouses and offers a temporary reprieve for industries on both sides of the Atlantic.The dispute traces back to a period of intensifying trade frictions, during which Washington sought to correct what it viewed as persistent imbalances and unfair practices in sectors…